Pharmaceutical Products Supply
Original notice title
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Opportunity Score
Why this score?
Opportunity
64 / 100
Complexity
78 / 100
Risk factors
The detailed nomenclature, quantities, product specifications and call-off conditions are not available. The stated val...
Participation requires pharmaceutical manufacturing, wholesale, import or equivalent authorisation, and additional cont...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Медицински институт на МВР
- Country
- Bulgaria
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Jul 09, 2029
- Estimated value
- EUR 13.7M
Overview
Moderate opportunityKey Facts
- EUR 13.7M estimated value
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Supply of pharmaceutical products under a dynamic purchasing system.
- The procurement period is 36 months.
Show full summary
Three-year dynamic purchasing system for the electronic procurement of pharmaceutical products for the Medical Institute of the Ministry of Interior in Bulgaria. The estimated value is EUR 13,698,329.85. The procedure is marked as restricted and requires electronic submission through the Bulgarian CAIS EOP platform. Eligibility requires pharmaceutical manufacturing, wholesale, import or equivalent authorization, with an additional controlled-substances licence for specified items. Procurement documents were not analyzed beyond the extracted XML notice, and the XML conflicts with the structured data regarding EU funding.
Risks
The detailed nomenclature, quantities, product specifications and call-off conditions are not available. The stated val...
Participation requires pharmaceutical manufacturing, wholesale, import or equivalent authorisation, and additional cont...
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- The procedure is identified as restricted and the procurement system as a dynamic purchasing system.
- The contract nature is supplies.
Administrative
- Electronic submission is required through the CAIS EOP platform.
Award Criteria
Lot 1
Buyer
Location
София, BGR
Website
Buyer profile
Identifier
129007218
Activity
Health
Lots (1)
LOT-0001
Dynamic Purchasing System for Pharmaceutical Product Supply
A three-year dynamic purchasing system for the supply of pharmaceutical products to the Medical Institute of the Ministry of Interior. Detailed product nomenclature and technical requirements are stated to be in Technical Specification Annex 1, which was not provided for analysis.
EUR 13.7M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Настоящата обществена поръчка се възлага въз основа на икономически най-изгодната оферта. Икономически най-изгодната оферта се определя въз основа на критерия за възлагане: "най-ниска цена", съгласно чл. 70, ал. 2, т. 1 от ЗОП. На оценка подлежи предложената обща крайна стойност без ДДС до втори знак след десетичната запетая за съответната номенклатурна единица.
Value note
Show original TED data
Original lot title
Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Original TED description
В рамките на Динамична система за покупки ще ще бъдат възлагани обществени поръчки за доставка на лекарствени продукти за Медицински институт на МВР за период от три години, подробно описани в Техническата спецификация на поръчката - Приложение № 1, неразделна част от Документацията за обществена поръчка и публикувана в досието на поръчката в ЦАИС ЕОП.
Procurement Details
- Publication date
- 09 Jul 2026
- Languages
- Bulgarian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 477547-2026
Documents (1)
Similar tenders
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Aflibercept, ausgenommen 114,3 mg/ml (ATC-Code: S01LA05).
Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption
Poland – Pharmaceutical products – DOSTAWA LEKÓW – 98 CZĘŚCI
Poland – Pharmaceutical products – ZP/CZD/140/26 Dostawa produktów leczniczych – 4 pakiety.
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Erythropoietin (ATC-Code: B03XA01).
Lithuania – Pharmaceutical products – Medikamentai
Opportunity Score
Why this score?
Opportunity
64 / 100
Complexity
78 / 100
Risk factors
The detailed nomenclature, quantities, product specifications and call-off conditions are not available. The stated val...
Participation requires pharmaceutical manufacturing, wholesale, import or equivalent authorisation, and additional cont...
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications